Cystic Fibrosis Flashcards

1
Q

Parkinson’s is the commonest inherited genetic condition in the UK.

True or False?

A

False

Cystic Fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cystic fibrosis is an ——– ——– condition.

A

Autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many people are carriers

A

1 in 25
1 in 2500 births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

97% of cystic fibrosis occurs in the

A

Caucasian population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many individuals with CF in the UK?

A

9000 individuals (approx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cystic fibrosis is

A

the mutation of a gene located on chromosom 7q31, which codes for a protein called cystic fibrosis transmembrane regulator (CFTR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the commonest mutation of CF?

A

Delta F5-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagram inheritance of CF

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CFTR protein

A
  • CF occurs due to a mutation in a gene on the long arm of chromosome 7
  • results in defect in the cystic fibrosis transmembrane conductance regulator protein
  • CFTR sits in the membrane of epithelial cells and regulates the transport of Cl- through activation of cyclic AMP and through calcium activated chloride channels
  • CFTR inhibits transport of sodium through the sodium channels in the epithelial cell membrane and regulates the movement of bicarbonate ions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

process of CFTR

A

insert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Impact of abnormal CFTR:

A
  • abnormal CFTR protein leads to decreased chloride reabsorption and increased sodium reabsorption
  • secretions have high viscosity and reduced water content
  • this impedes mucociliary clearance in the bronchi so respiratory secretions are stagnant
  • decreased defence from respiratory infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

consequenc of recurring infections in the lungs

A

bronchiectasis

  • recurring infections causes constant inflammation in the lungs, terminal and respiratory bronchioles not major airways
  • causes destruction and dilation of the distal airways with mucous impaction, which predisposes to more infection which predisposes to worsening of the inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

insert chest x ray

A

bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Common organs affected by CF?

A
  • Respiratory System:
    • bronchiectasis
    • recurrent respiratory infections
    • respiratory infections
  • Gastrointestinal System:
    • pancreatic insufficiency
    • diabetic mellitus
  • Skin:
    • increased sweat, when exercising can lose a lot of sodium
  • Reproductive system:
    • infertile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CF process fill out

A

insert

17
Q

Symptoms of upper respiratory tract in CF:

A
  • chronic sinus disease
  • nasal polyps
18
Q

Symptoms of lower respiratory tract:

A
  • chronic cough and sputum
  • bronchiectasis (dilated and inflamed bronchi)
  • chronic suppurative lung disease (pus)
  • colonisation with bacteria
  • frequent respiratory infections
  • clubbing
19
Q

Common bacteria causing disease in CF and consequence:

A
  • Staphylococcus aureus
  • Haemopilus influenzae
  • pseudomonas aeruginosa (grram +)
  • burholderia cepacia (gram -)
  • colonisation
  • difficult to eradicate
20
Q

Insert chest x ray

A

insert

21
Q

insert CT scan

A

insert

22
Q

CF: gastrointestinal tract flow chart:

A

insert

23
Q

Impact of CF on gastrointestinal disease:

A
  • defective CFTR leads to abnormal chloride transport in pancrease leads to destruction of pancreas and exocrine insufficiency
  • decrease in lipase activity
  • decreased absorption of fat in small intestine
  • steatorrhoea (fat in tstool, pale and floats)
  • decreased water content in intestines leads to thick faecal material leads to intestinal obstruction: “meconium ileus equivalent” in adults as it mimics meconium ileus in neonates”
  • COMPLETE
24
Q

CF presentations in newborn

A
  • meconium ileus
  • failure to thrive
  • recurrent respiratory infections
25
Q

Three types/times of screening for CF:

A
  • antenatal
  • prenatal
  • neonatal
26
Q

Antenatal screening for CF:

A
  • after birth
  • carrier testing
  • genetic counselling
27
Q

Prenatal screening for CF:

A
  • DNA analysis on sample of chorionic villus
  • amniocentesis
  • allows reproductive decision making
28
Q

Neonatal screening for CF:

A
  • newborn screening
  • Futhrie test
  • sweat test
29
Q

Why is screening for Cf useful?

A
  • early diagnosis and treatment improves outcome
30
Q

Diagnosis of CF:

A
  • clinical presentation:
    • recurrent respiratory infection
    • meconium ileus
    • Failure to thrive
  • positive sweat test = chloride content > 60mmol/L = abnormal
  • DNA analysis: genotyping for common mutations
  • chest x ray usually abnormal
31
Q

diagram

A

insert

32
Q

Management of CF:

A
  • specialist centre
  • MDT:
    • nurse specialists, dieticians, OT, psych, support for family, etc
  • CF trust
33
Q

Treatment of respiratory disease (CF):

A
  • prompt antibiotics for respiratory infections
  • intense chest physio to remove mucus; once or twice a day
  • nebulised DNAse (breaks down DNA of secretions and bacteria) leads to a decrease in viscosity
  • mucolytic drugs
  • bronchodilators
  • long term oxygen therapy
  • lung or heart transplant
34
Q

Management of pancreatic disease (CF):

A
  • exocrine:
    • creaon (pancreatic enzymes)
    • multivitamins
    • nutritional support (enteral feeding)
  • endocrine (diabetes):
    • insulin
35
Q

median survival years diagram

A

insert

36
Q

Potential new treatments for CF:

A
  • gene therapy
  • RNA correction
  • CTFR modulation
37
Q

Gene Therapy for CF improves

A
  • Kaftrio: triple therapy
  • Potentiator and corrector impact on production and function
  • improves symptoms
  • improves lung function
  • improves survival